From HalfDays:
Jan 29: Atrial Fibrillation (Dr. Guyatt & Dr. Healey)
|
The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) A comparison of rate control and rhythm control in patients with atrial fibrillation. NEJM 2002 Dec 5; 347(23):1825-33. AFFIRM.pdf (165kb)  |
|
Taylor FC, Cohen H, Ebrahim S. Systematic review of long term anticoagulation or antiplatelet treatment in patients with non-rheumatic atrial fibrillation BMJ 2001 Feb 10; 322:321-6. AFibReview.pdf (293kb) |
Nov 10: Congenital Heart Disease (Dr. O. Salehian)
|
Congenital Heart Disease in Adults Part 1: NEJM 2000 Jan 27; 342(4):256-63. congNEJM1.pdf Part 2: NEJM 2000 Feb 3; 342(5):334-42. congNEJM2.pdf |
|
Challenges Posed by Adults With Repaired Congenital Heart
Disease.
Circulation 2001 May 29; 103:2637-43. congHDperloff.pdf |
|
Case Presentation. congHDcase.doc |
Oct 24: CURE, ESSENCE and GIM (Dr. H. Lee)
|
Effects of Clopidogrel in Addition to Aspirin in Patients with
Acute Coronary Syndromes Without ST-segment Elevation. NEJM 2001 Aug 16; 345(7):494-502. CURE.pdf |
|
Effects of pretreatment with clopidogrel and aspirin followed
bylong-term therapy in patients undergoing percutaneous
coronaryintervention: the PCI-CURE study. Lancet 2001 Aug 18; 358:527-33. PCI-CURE.pdf |
|
A Comparison of Low-Molecular-Weight Heparin with Unfractionated
Heparin for Unstable Coronary Artery Disease. NEJM 1997 Aug 14; 337(7):447-52. ESSENCE.pdf |
|
Case Presentation. scenario.doc |
Useful Cardiology Articles
The HOPE Trial
Effects of an angiotensin-converting-enzyme inhibitor, Ramipril, on cardiovascular events in high-risk patients.
NEJM 2000 Jan 20; 342:145-53.
HOPE.pdf